Volume 13, Number 7—July 2007
Research
Antiretroviral Therapy during Tuberculosis Treatment and Marked Reduction in Death Rate of HIV-Infected Patients, Thailand1
Somsak Akksilp*, Opart Karnkawinpong*, Wanpen Wattanaamornkiat*, Daranee Viriyakitja†, Patama Monkongdee‡, Walya Sitti*, Dhanida Rienthong†, Taweesap Siraprapasiri†‡, Charles D. Wells§, Jordan W. Tappero‡§, and Jay K. Varma†§
Table 2
Results of culture and susceptibility testing performed on HIV-infected patients with pulmonary TB, stratified by sputum smear–positive versus –negative results, Ubon-ratchathani, February 2003 through January 2004*
| Characteristic | Smear-positive (n = 120), no. (%) | Smear-negative (n = 107), no. (%) |
|---|---|---|
| Sputum culture performed | 93/120 (78) | 52/107 (49) |
| Culture positive for nontuberculous mycobacteria | 2/93 (2) | 0/52 (0) |
| Contaminated | 5/93 (5) | 6/52 (12) |
| Culture negative | 21/93 (23) | 43/52 (83) |
| Culture positive for Mycobacterium tuberculosis | 65/93 (70) | 3/52 (6) |
| Multidrug-resistant TB | 4/65 (6) | 0/3 (0) |
| Previously treated | 1/4 (25) | NA |
*TB, tuberculosis; NA, not available.
